These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7099073)

  • 61. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
    Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
    Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of methicillin-resistant Staphylococcus aureus infections.
    Med Lett Drugs Ther; 1982 Dec; 24(624):107-8. PubMed ID: 6924065
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Methicillin resistant staphylococcus aureus (MRSA): incidence is growing in French-speaking Switzerland].
    Blanc DS; Troillet N; Siegrist HH; Fracheboud D; Petignat C; Francioli P
    Rev Med Suisse Romande; 2001 Apr; 121(4):309-12. PubMed ID: 11400404
    [No Abstract]   [Full Text] [Related]  

  • 67. A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
    Cunha BA
    J Hosp Infect; 2008 Mar; 68(3):271-3. PubMed ID: 18289722
    [No Abstract]   [Full Text] [Related]  

  • 68. Tourniquets and nosocomial methicillin-resistant Staphylococcus aureus infections.
    Berman DS; Schaefler S; Simberkoff MS; Rahal JJ
    N Engl J Med; 1986 Aug; 315(8):514-5. PubMed ID: 3637628
    [No Abstract]   [Full Text] [Related]  

  • 69. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 70. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The carrier state: methicillin-resistant Staphylococcus aureus.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():1-12. PubMed ID: 3091562
    [No Abstract]   [Full Text] [Related]  

  • 72. Methicillin-resistant Staphylococcus aureus bacteraemia.
    McDonald M; Hurse A; Sim KN
    Med J Aust; 1981 Aug; 2(4):191-4. PubMed ID: 7029225
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current problems with methicillin-resistant Staphylococcus aureus.
    Marples RR; Cooke EM
    J Hosp Infect; 1988 May; 11(4):381-92. PubMed ID: 2899592
    [No Abstract]   [Full Text] [Related]  

  • 74. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Acute bacterial parotiditis due to methicillin-resistant Staphylococcus aureus in the institutionalized elderly].
    Molina JC; Altés J; Vera R; Vilamala A
    Enferm Infecc Microbiol Clin; 2003; 21(6):325-6. PubMed ID: 12809596
    [No Abstract]   [Full Text] [Related]  

  • 76. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibiotic-resistant staphylococci in a teaching hospital.
    King K; Brady L; Thomson M; Harkness JL
    Med J Aust; 1982 Nov; 2(10):461-5. PubMed ID: 6925145
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Update on emerging infections: news from the Centers for Disease Control and Prevention.
    Moran GJ; Mount J
    Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697
    [No Abstract]   [Full Text] [Related]  

  • 79. Staphylococcal infections in hospital.
    Shanson DC
    Br J Hosp Med; 1986 May; 35(5):312, 314, 318-20. PubMed ID: 3636159
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Methicillin-resistant Staphylococcus aureus: is it a problem in Mexico?].
    Sifuentes-Osornio J
    Bol Med Hosp Infant Mex; 1989 Nov; 46(11):697-9. PubMed ID: 2631737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.